Nathalie Leclercq

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer.

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer.

Journal: Frontiers in oncology

Published: July 07, 2017

A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.

A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 18, 2016

Implementation of an oncological care program in a multidisciplinary clinic

Implementation of an oncological care program in a multidisciplinary clinic

Journal: Revue des maladies respiratoires

Published: July 28, 2015

Difficulties and limitations in conducting translational research in thoracic oncology. A practical example

Difficulties and limitations in conducting translational research in thoracic oncology. A practical example

Journal: Revue des maladies respiratoires

Published: June 29, 2015

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study.

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study.

Journal: ERJ open research

Published: May 22, 2015

Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party.

Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party.

Journal: Frontiers in oncology

Published: October 17, 2014

An ELCWP phase III trial comparing ifosfamide and cisplatin regimens in advanced NSCLC.

An ELCWP phase III trial comparing ifosfamide and cisplatin regimens in advanced NSCLC.

Journal: Anticancer research

Published: December 11, 2013

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study.

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 19, 2013

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working Party.

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working Party.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 13, 2011

Showing 1-9 of 9

Last Updated: 09/26/2026